Identification | More | [Name]
D-Aspartic acid | [CAS]
1783-96-6 | [Synonyms]
D-2-AMINOBUTANEDIOIC ACID D-AMINOSUCCINIC ACID D-ASP D-ASPARAGINIC ACID D-(-)-ASPARTIC ACID D-ASPARTIC ACID H-D-ASP-OH (R)-2-AMINOSUCCINIC ACID (R)-(-)-AMINOSUCCINIC ACID (R)-AMINOSUCCINIC ACID (R)-(-)-ASPARTIC ACID 1-Amino-1,2-carboxyethane d-aspartic d-asparticaci l-Asparagic acid (R)-(-)-Aminosuccinic acid(R)-2-Aminosuccinic acid D-ASPARTIC ACID CRYSTALLINE D0001H-D-Asp-Oh D-Aminosuccinicacid=H-D-Asp-OH D(-)-Aspartic acid, 99+% | [EINECS(EC#)]
217-234-6 | [Molecular Formula]
C4H7NO4 | [MDL Number]
MFCD00063081 | [Molecular Weight]
133.1 | [MOL File]
1783-96-6.mol |
Chemical Properties | Back Directory | [Appearance]
White or almost white crystalline powder | [Melting point ]
>300 °C(lit.)
| [alpha ]
-25.8 º (c=5, 5N HCl) | [Boiling point ]
245.59°C (rough estimate) | [density ]
1.66 | [refractive index ]
-25 ° (C=8, 50% HCl) | [storage temp. ]
Store at RT. | [solubility ]
Aqueous Acid (Sparingly) | [form ]
Crystalline Powder | [pka]
pK1: 1.89(0);pK2: 3.65;pK3: 9.60 (25°C) | [color ]
White to off-white | [optical activity]
[α]20/D 24°, c = 2.3 in 6 M HCl | [Water Solubility ]
SOLUBLE | [Detection Methods]
T,NMR,Rotation | [Merck ]
14,840 | [BRN ]
1723529 | [InChIKey]
CKLJMWTZIZZHCS-UWTATZPHSA-N | [LogP]
-1.075 (est) | [CAS DataBase Reference]
1783-96-6(CAS DataBase Reference) | [NIST Chemistry Reference]
D-aspartic acid(1783-96-6) |
Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S24/25:Avoid contact with skin and eyes . S36:Wear suitable protective clothing . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [WGK Germany ]
3
| [RTECS ]
CI9097500
| [HS Code ]
29224900 |
Hazard Information | Back Directory | [Chemical Properties]
White or almost white crystalline powder | [Uses]
A non-essential amino acid found in food sources and dietary supplements. D-Aspartic acid's conjugate base D-aspartate has potential use as a a therapeutic agent in the treatment of schizophrenia-related symptoms.
| [Definition]
ChEBI: The D-enantiomer of aspartic acid. | [reaction suitability]
reaction type: solution phase peptide synthesis | [Biological Activity]
Endogenous NMDA receptor agonist with similar activity to the L-isomer (L-Aminosuccinic acid ). Also a non-metabolizable substrate for EAA uptake systems. Modulates melatonin synthesis in the pineal gland. | [storage]
Room temperature |
|
|